Article
Integrated single-cell, spatial, and bulk transcriptomics reveal a chromatin regulator-TME prognostic framework guiding precision therapy in cervical cancer.
Journal of translational medicine - 6 Nov 2025
Tian Xiong, Lin Rong, Bao Jiaqian, Pan Yixiao, Liu Jianbo, Zhou Hanxi, Qu Hangshuai, Hu Dali, Wang Na
Abstract excerpt
BACKGROUND: Chromatin regulators (CRs) play a critical role in tumorigenesis, drug response, and prognosis, with dysregulation of chromatin regulator genes (CRGs) potentially disrupting the tumor immune microenvironment (TME) and influencing immune responses in cervical cancer. However, the prognostic and therapeutic implications of integrating CRGs and TME parameters in cervical cancer remain poorly understood....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
